ACR urges CMS to make changes to lung cancer screening guidance
The American College of Radiology (ACR) is urging the U.S. Centers for Medicar...Read more on AuntMinnie.comRelated Reading: ACR: Biden's stopgap spending bill comes up short for radiology ACR mulls legal action over No Surprises Act implementation ACR DSI launches AI federated learning program ACR lauds new lung cancer screening guidelines from CMS ACR sees benefits for radiology in the 2022 HOPPS rule (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - December 7, 2021 Category: Radiology Source Type: news

AI can predict mortality from DEXA body composition data
Changes in body composition over time can be identified on total-body dual-energ...Read more on AuntMinnie.comRelated Reading: Body composition analysis predicts mortality in spinal metastases Body composition on CT lung screening can spot at-risk patients Can body composition metrics foretell COVID-19 patient outcomes? Chest CT assesses COPD mortality risk AI body analysis finds lung cancer survival risk factors (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - December 7, 2021 Category: Radiology Source Type: news

Medicare spending for diagnostic imaging fell 16% in 2020
Medicare physician services spending for imaging fell 16% in 2020, from an expecte...Read more on AuntMinnie.comRelated Reading: Regulatory and payment issues that will impact radiology in 2022 Medicare beneficiary growth outstripping radiologist supply CMS releases 2022 Medicare Physician Fee Schedule final rule CMS proposes expanded payment for CT lung cancer screening CMS officially kills 'breakthrough' medical device program (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - December 6, 2021 Category: Radiology Source Type: news

New PET tracer detects lung tumors
An experimental PET radiotracer is safe and appears effective for detectin...Read more on AuntMinnie.comRelated Reading: PET tracer proves effective for assessing immunotherapy Quitting smoking slows early lung cancer progression CT identifies candidates for sublobar resection for lung cancer CT radiomics predicts survival in NSCLC patients Falling lung cancer rates drive cancer decline in U.S. (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - December 3, 2021 Category: Radiology Source Type: news

KRAS Mutation Predicts Pembrolizumab Response in NSCLC KRAS Mutation Predicts Pembrolizumab Response in NSCLC
A new study, published as a preprint, reported a better way to predict if patients with metastatic nonsmall cell lung cancer will respond to pembrolizumab.First Look (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - December 3, 2021 Category: Cancer & Oncology Tags: Hematology-Oncology News Source Type: news

Including more Black smokers in lung screening would save lives
Increasing the number of African American and Black smokers who get screene...Read more on AuntMinnie.comRelated Reading: ACR lauds new lung cancer screening guidelines from CMS Community radiology well-placed to offer smoking cessation support CMS proposes expanded payment for CT lung cancer screening Lung cancer survival up, but not necessarily for minorities Stricter Lung-RADS protocol helps reclassify nodules on follow-up CT (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - December 2, 2021 Category: Radiology Source Type: news

Boulder-based Biodesix Inc. partners with Tennessee med tech startup on diagnostic testing
Spesana has partnered with Biodesix Inc., a Boulder-based diagnostics solutions business that provides molecular diagnostics tests, with a focus on lung cancer. (Source: bizjournals.com Health Care:Biotechnology headlines)
Source: bizjournals.com Health Care:Biotechnology headlines - December 2, 2021 Category: Biotechnology Authors: John Klyce Source Type: news

Lung cancer warning: The 'surprising' symptom of lung cancer on your hands
LUNG CANCER is one of the most common cancers in the UK and is very difficult to diagnose in the early stages. What is the unusual symptom on your hands you should never ignore? (Source: Daily Express - Health)
Source: Daily Express - Health - December 2, 2021 Category: Consumer Health News Source Type: news

Innovative lung cancer treatment
More than 600 people could benefit from an innovative drug for a form of lung cancer as NICE publishes final draft guidance recommending osimertinib within the cancer drugs fund. (Source: NHS Networks)
Source: NHS Networks - December 2, 2021 Category: UK Health Source Type: news

Local med tech startup Spesana partners with Colorado-based public company Biodesix Inc. to provide more molecular diagnostic tests
Spesana has partnered with Biodesix Inc., a Colorado-based diagnostics solutions business that provides molecular diagnostics tests, with a focus on lung cancer. (Source: bizjournals.com Health Care:Biotechnology headlines)
Source: bizjournals.com Health Care:Biotechnology headlines - December 1, 2021 Category: Biotechnology Authors: John Klyce Source Type: news

Adjuvant Atezo in Stage II/IIIA Lung Cancer: A New Standard? Adjuvant Atezo in Stage II/IIIA Lung Cancer: A New Standard?
Dr Mark Kris discusses a recent trial demonstrating improved disease-free survival for patients with resected stage II to IIIA, PD-L1-positive lung cancer treated with atezolizumab following cisplatin-based chemotherapy.Medscape Oncology (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - December 1, 2021 Category: Consumer Health News Tags: Hematology-Oncology Commentary Source Type: news

Can Aspirin Prolong Survival in Patients With NSCLC? Can Aspirin Prolong Survival in Patients With NSCLC?
A new study shows that people with inoperable non-small cell lung cancer who took the cheap painkiller survived longer, but questions linger.Medscape Medical News (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - December 1, 2021 Category: Cancer & Oncology Tags: Hematology-Oncology News Source Type: news

The Roles and Therapeutic Potential of Clusterin in NSCLC The Roles and Therapeutic Potential of Clusterin in NSCLC
A better understanding of the clinical relevance of clusterin in non-small cell lung cancer could lead to the development of more effective targeted therapies.Translational Lung Cancer Research (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - December 1, 2021 Category: Consumer Health News Tags: Hematology-Oncology Journal Article Source Type: news

Tips to Reduce Treatment Downtime in Lung Cancer Tips to Reduce Treatment Downtime in Lung Cancer
Dr Mark Kris discusses waiting in the oncology setting, focusing on the importance of communication with colleagues and with patients.Medscape Oncology (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - November 29, 2021 Category: Cancer & Oncology Tags: Hematology-Oncology Commentary Source Type: news

Diagnosis and Treatment of Non-Small Cell Lung Cancer: From Where We Have Been to Where We Are Going Diagnosis and Treatment of Non-Small Cell Lung Cancer: From Where We Have Been to Where We Are Going
Sandip Patel, MD, describes a changing oncologic landscape in which treatment of non-small cell lung cancer (NSCLC) has given rise to new modes and values.Medscape (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - November 29, 2021 Category: Consumer Health News Tags: None MDAngle Source Type: news

Blueprint Medicines to Expand Precision Therapy Leadership in Lung Cancer with Acquisition of Lengo Therapeutics
Adds LNG-451, a highly selective brain-penetrant precision therapy targeting EGFR exon 20 insertion mutations, to Blueprint Medicines' lung cancer pipeline Lengo Therapeutics on track to submit IND to FDA for LNG-451 by the end of 2021 Lengo Therapeu... Biopharmaceuticals, Oncology, Mergers & Acquisitions Blueprint Medicines, Lengo Therapeutics, precision therapy, NSCLC (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - November 29, 2021 Category: Pharmaceuticals Source Type: news

Novarad integrates PenRad lung screening software into PACS
Healthcare IT company Novarad is set to offer lung cancer screening softwar...Read more on AuntMinnie.comRelated Reading: Novarad launches new version of CryptoChart Novarad signs deal with health center in Iowa Novarad debuts free AI software for COVID-19 PenRad debuts patient notification software PenRad gives lung CT tracker to imaging centers (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - November 28, 2021 Category: Radiology Source Type: news

Median touts iBiopsy clinical results
Median Technologies is highlighting clinical results that show that its iBiops...Read more on AuntMinnie.comRelated Reading: Median highlights AI lung cancer research Median posts 51% revenue increase for fiscal year 2020 Median taps new chief operating and commercial officer Median signs research deal with UC San Diego Median logs 51% growth in annual revenues (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - November 23, 2021 Category: Radiology Source Type: news

VA says veteran died after delayed lung cancer diagnosis
Poor oversight of resident physicians may have contributed to the death of ...Read more on AuntMinnie.com (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - November 23, 2021 Category: Radiology Source Type: news

Treatment of Non-Small Cell Lung Cancer: Picking the Best Path Treatment of Non-Small Cell Lung Cancer: Picking the Best Path
Sandip Patel, MD, advises clinicians early in their careers that choosing exemplary care of patients with non-small cell lung cancer can be like finding the right path on a map.Medscape (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - November 23, 2021 Category: Consumer Health News Tags: Hematology-Oncology MDAngle Source Type: news

Lung cancer symptoms: The sign in the arm and shoulder that can signal the deadly disease
CATCHING lung cancer before it has the chance to develop or spread is often the best hope of treating it. (Source: Daily Express - Health)
Source: Daily Express - Health - November 20, 2021 Category: Consumer Health News Source Type: news

CMS Change to Reimbursement for Lung Cancer Screening CMS Change to Reimbursement for Lung Cancer Screening
The proposed guidance would lower the age for initiating screening, reduce the number of pack-years smoked, and bring screening more in line with the latest recommendations from the USPSTF.Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - November 19, 2021 Category: Consumer Health News Tags: Hematology-Oncology News Source Type: news

European Commission approves Roche ’s Gavreto (pralsetinib) for the treatment of adults with RET fusion-positive advanced non-small cell lung cancer
Basel, 19 November 2021 - Roche (SIX: RO, ROG; OTCQX: RHHBY) today announced that the European Commission (EC) has granted conditional marketing authorisation for Gavreto ® (pralsetinib) as a monotherapy for the treatment of adults with rearranged during transfection (RET) fusion-positive advanced non-small cell lung cancer (NSCLC) not previously treated with a RET inhibitor. Gavreto is the first and only precision medicine approved in the European Union (EU) for th e first-line treatment of people with RET fusion-positive advanced NSCLC.1 (Source: Roche Media News)
Source: Roche Media News - November 19, 2021 Category: Pharmaceuticals Source Type: news

European Commission approves Roche ’s Gavreto (pralsetinib) for the treatment of adults with RET fusion-positive advanced non-small cell lung cancer
Basel, 19 November 2021 - Roche (SIX: RO, ROG; OTCQX: RHHBY) today announced that the European Commission (EC) has granted conditional marketing authorisation for Gavreto ® (pralsetinib) as a monotherapy for the treatment of adults with rearranged during transfection (RET) fusion-positive advanced non-small cell lung cancer (NSCLC) not previously treated with a RET inhibitor. Gavreto is the first and only precision medicine approved in the European Union (EU) for th e first-line treatment of people with RET fusion-positive advanced NSCLC.1 (Source: Roche Investor Update)
Source: Roche Investor Update - November 19, 2021 Category: Pharmaceuticals Source Type: news

ACR lauds new lung cancer screening guidelines from CMS
The American College of Radiology (ACR) is lauding proposed new guidelines fro...Read more on AuntMinnie.comRelated Reading: CMS proposes expanded payment for CT lung cancer screening ACR sees benefits for radiology in the 2022 HOPPS rule ACR publishes pediatric CT radiation dose benchmarks ACR updates appropriateness criteria (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - November 19, 2021 Category: Radiology Source Type: news

Lung cancer symptoms: Three of the 'most important symptoms' of a growing tumour
LUNG cancer is "by far" the most common cause of cancer death in the UK, reported Cancer Research UK, killing more than 35,000 people each year. (Source: Daily Express - Health)
Source: Daily Express - Health - November 18, 2021 Category: Consumer Health News Source Type: news

CMS proposes expanded payment for CT lung cancer screening
The U.S. Centers for Medicare and Medicaid Services (CMS) on November 17 release...Read more on AuntMinnie.comRelated Reading: Is the 2021 USPSTF lung cancer screening guidance cost-effective? Black individuals may not benefit from wider lung screening guidance CT lung cancer screening guidelines are changing Do the USPSTF lung cancer guidelines cause screening disparities? USPSTF's new lung cancer screening guidance lowers starting age (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - November 18, 2021 Category: Radiology Source Type: news

How will AI affect radiologist productivity?
Artificial intelligence (AI) software can offer much value in radiology. Bu...Read more on AuntMinnie.comRelated Reading: Radiologists boost AI severity quantification of COVID-19 Report: Reimbursement drives adoption of AI software for stroke Can AI help detect cancer on CT lung cancer screening exams? Can AI help screen for early interstitial lung disease on x-rays? CT radiomics helps predict spontaneous intracerebral hemorrhage (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - November 18, 2021 Category: Radiology Source Type: news

Consumer Health: Are you ready to quit smoking?
Quitting smoking is one of the best things you can do for your health and your family's health. Quitting smoking can add years to your life, and it's never too late to see the health benefits of quitting. Lung cancer claims more lives each year than colon, breast and prostate cancers combined. Although the disease can occur in people who have never smoked, people who smoke or have smoked have the greatest risk of lung… (Source: News from Mayo Clinic)
Source: News from Mayo Clinic - November 18, 2021 Category: Databases & Libraries Source Type: news

Treatment of Advanced Non-Small Cell Lung Cancer: From the Impossible to the Possible Treatment of Advanced Non-Small Cell Lung Cancer: From the Impossible to the Possible
How developments in the field of advanced non-small cell lung cancer have led Dr H. Jack West to"question whether what we thought was once impossible, is now possible."Medscape (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - November 17, 2021 Category: Consumer Health News Tags: Hematology-Oncology MDAngle Source Type: news

Lung Cancer Survival Continues to Improve, But Not for All
Title: Lung Cancer Survival Continues to Improve, But Not for AllCategory: Health NewsCreated: 11/16/2021 12:00:00 AMLast Editorial Review: 11/17/2021 12:00:00 AM (Source: MedicineNet Cancer General)
Source: MedicineNet Cancer General - November 17, 2021 Category: Cancer & Oncology Source Type: news

Lung cancer survival up, but not necessarily for minorities
A new report released November 16 by the American Lung Association (ALA) ha...Read more on AuntMinnie.comRelated Reading: Stricter Lung-RADS protocol helps reclassify nodules on follow-up CT 5 ways radiologists can contribute to population health management Patients less likely to get lung screening after diagnostic CT Can AI help detect cancer on CT lung cancer screening exams? USPSTF's new lung cancer screening guidance lowers starting age (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - November 16, 2021 Category: Radiology Source Type: news

One Quarter of Lung Cancer Patients Alive at 5 Years One Quarter of Lung Cancer Patients Alive at 5 Years
Survival of lung cancer has improved so much in recent years that now almost one quarter of patients with lung cancer are still alive 5 years after being diagnosed.Medscape Medical News (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - November 16, 2021 Category: Cancer & Oncology Tags: Hematology-Oncology News Source Type: news

Too Soon to Utter the Word'Cure' in Advanced Lung Cancer? Too Soon to Utter the Word'Cure' in Advanced Lung Cancer?
Oncologist Jack West explores whether it's appropriate to use the word"cure" for some patients with advanced lung cancer.Medscape Oncology (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - November 16, 2021 Category: Cancer & Oncology Tags: Hematology-Oncology Commentary Source Type: news

UCLA scientists make strides toward an ‘off-the-shelf’ immune cell therapy for cancer
Immunotherapies, which harness the body ’s natural defenses to combat disease, have revolutionized the treatment of aggressive and deadly cancers. But often, these therapies — especially those based on immune cells — must be tailored to the individual patient, costing valuable time and pushing their price into the hundreds of thousa nds of dollars.Now, in a study published in the journal Cell Reports Medicine, UCLA researchers report a critical step forward in the development of an “off-the-shelf” cancer immunotherapy using rare but powerful immune cells that could potentially be produced...
Source: UCLA Newsroom: Health Sciences - November 16, 2021 Category: Universities & Medical Training Source Type: news

How Baptist Cancer Center 'Miracle' aims to reduce local lung cancer mortality
How Baptist Cancer Center's 'Miracle' aims to reduce local lung cancer mortality by 25% by 2030. (Source: bizjournals.com Health Care:Physician Practices headlines)
Source: bizjournals.com Health Care:Physician Practices headlines - November 16, 2021 Category: American Health Authors: Aishwarya Airy Source Type: news

EU Panel Endorses First-of-Its-Kind Lung Cancer Drug EU Panel Endorses First-of-Its-Kind Lung Cancer Drug
Sotorasib is the first drug to successfully target KRAS mutations in non-small cell lung cancer.International Approvals (Source: Medscape Radiology Headlines)
Source: Medscape Radiology Headlines - November 15, 2021 Category: Radiology Tags: Hematology-Oncology News Alert Source Type: news

PNAS Retracts Paper That Contributed to Lung Cancer Trial PNAS Retracts Paper That Contributed to Lung Cancer Trial
An institutional investigation concluded that one of the researchers had falsified the data in that article and at least four others.Retraction Watch (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - November 15, 2021 Category: Consumer Health News Tags: Hematology-Oncology News Source Type: news

Stricter Lung-RADS protocol helps reclassify nodules on follow-up CT
Stricter Lung-RADS categories in terms of nodule size help clinicians to categoriz...Read more on AuntMinnie.comRelated Reading: Patients less likely to get lung screening after diagnostic CT Can AI help detect cancer on CT lung cancer screening exams? CT finds secondary lung disease in head and neck cancer survivors Is the 2021 USPSTF lung cancer screening guidance cost-effective? Body composition on CT lung screening can spot at-risk patients (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - November 15, 2021 Category: Radiology Source Type: news

Cancer mortality declined by 27% over past five decades
Substantial progress has been made in reducing mortality from cancer, with rate...Read more on AuntMinnie.comRelated Reading: Screening, socioeconomic status linked to breast cancer mortality Is the 2021 USPSTF lung cancer screening guidance cost-effective? Could scanning more Black people boost benefits of lung screening? Breast imaging capacity impacted by pandemic Breast cancer incidence to increase by 2040, but not mortality (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - November 12, 2021 Category: Radiology Source Type: news

Newspath April 2014 - Prostate Specific Antigen and Prostate Cancer Screening: Update on the Current Research and Recommendations
Prostate cancer is the most common cancer among men in the United States, killing 34,000 men per year, ranking it the second deadliest cancer of males, following lung cancer. (Source: NewsPath - Pathology News for the Medical Community)
Source: NewsPath - Pathology News for the Medical Community - November 11, 2021 Category: Pathology Source Type: news

Britain's lung cancer care REVERSED 25 years because of pandemic experts tell MPs
MPs have been told how pandemic guidance discouraged people with lung cancer from seeking medical help and it was equivalent to losing 25 years of progress in treating the disease. (Source: the Mail online | Health)
Source: the Mail online | Health - November 9, 2021 Category: Consumer Health News Source Type: news

Precision Medicine Turns to Proteins for Lung Cancer Targets
Probing the protein landscape in lung cancers reveals new therapeutic insights. (Source: The Scientist)
Source: The Scientist - November 9, 2021 Category: Science Tags: Sponsored Article Source Type: news

Patients less likely to get lung screening after diagnostic CT
Patients who are referred for a diagnostic chest CT scan to follow up suspiciou...Read more on AuntMinnie.comRelated Reading: Can AI help detect cancer on CT lung cancer screening exams? CT finds secondary lung disease in head and neck cancer survivors Is the 2021 USPSTF lung cancer screening guidance cost-effective? Black individuals may not benefit from wider lung screening guidance New CT lung cancer screening guide should fix healthcare inequities (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - November 9, 2021 Category: Radiology Source Type: news

Lung cancer symptoms: The three 'early' signs of lung cancer you might be missing
LUNG cancer symptoms might be easily confused for something less serious, but there are some tell-tale signs to look out for. These are the three "early" symptoms of lung cancer that aren't as common as a persistent cough or difficulty breathing. (Source: Daily Express - Health)
Source: Daily Express - Health - November 4, 2021 Category: Consumer Health News Source Type: news

Lung cancer symptoms: Two signs on your eyes - 'see your doctor right away'
LUNG cancer symptoms do not always develop in the early stages of lung cancer, but many people with the condition eventually develop symptoms. These may include a cough that does not go away or gets worse. (Source: Daily Express - Health)
Source: Daily Express - Health - November 3, 2021 Category: Consumer Health News Source Type: news

EXKIVITY (mobocertinib), First and Only FDA Approved Oral Treatment for EGFR Exon20 Insertion+ Metastatic Non-Small Cell Lung Cancer, Available at Biologics by McKesson
CARY, N.C., Nov. 3, 2021 —Biologics by McKesson, an independent specialty pharmacy specializing in oncology and rare disease areas, was selected by Takeda Pharmaceutical Limited Company as a specialty pharmacy provider for EXKIVITYTM (mobocertinib) for the treatment of adult patients with locally adv... (Source: McKesson News)
Source: McKesson News - November 3, 2021 Category: Information Technology Source Type: news

More Lung Cancer Patients Are Surviving, Thriving
Title: More Lung Cancer Patients Are Surviving, ThrivingCategory: Health NewsCreated: 11/2/2021 12:00:00 AMLast Editorial Review: 11/3/2021 12:00:00 AM (Source: MedicineNet Cancer General)
Source: MedicineNet Cancer General - November 3, 2021 Category: Cancer & Oncology Source Type: news

Study Supports Opdivo as Second-Line Mesothelioma Treatment
When the effectiveness of first-line chemotherapy fails and malignant mesothelioma returns, more patients could soon turn with confidence to a proven, second-line treatment. The first phase III, placebo-controlled, double-blind clinical trial studying the safety and efficacy of Opdivo, the immunotherapy drug known generically as nivolumab, has raised the level of confidence in this option for patients with relapsed disease. “The evidence is robust, the survival significant,” Dr. Dean Fennell, chair of Thoracic Medical Oncology, University of Leicester and University Hospitals in the United Kingdom, told T...
Source: Asbestos and Mesothelioma News - November 2, 2021 Category: Environmental Health Authors: Fran Mannino Source Type: news